Skip to main content
. 2018 Sep 6;2018:9793850. doi: 10.1155/2018/9793850

Table 3.

Results of multivariate analysis.

All patients Without levothyroxine therapy With levothyroxine therapy
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Positive anti-TPO 2.21 (1.14–4.28) 0.018 2.28 (1.01–5.12) 0.047 1.91 (0.59–6.21) 0.281
Ultrasound signs of Hashimoto's thyroiditis 1.13 (0.57–2.24) 0.74 1.30 (0.55–3.06) 0.552 0.86 (0.25–2.91) 0.810
Levothyroxine therapy 0.69 (0.36–1.33) 0.27
TSH <0.5 mIU/l 0.41 (0.19–0.88) 0.02 0.30 (0.12–0.75) 0.010 1.09 (0.23–5.16) 0.914
Thyroid volume > 75th percentile (18 ml) 1.21 (0.65–2.24) 0.56 1.51 (0.77–2.96) 0.234 0.30 (0.03–2.72) 0.282

TSH: thyroid-stimulating hormone; anti-TPO: antibodies against thyroid peroxidase; anti-Tg: antithyroglobulin antibody. Antibodies against thyroglobulin were excluded from the multivariate regression analysis due to missing data.